ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
159 hedge funds and large institutions have $1.17B invested in iTeos Therapeutics in 2022 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 50 increasing their positions, 41 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
159
Holders Change
+41
Holders Change %
+34.75%
% of All Funds
2.52%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.08%
New
54
Increased
50
Reduced
41
Closed
11
Calls
$343K
Puts
$2.07M
Net Calls
-$1.73M
Net Calls Change
-$1.73M
Top Buyers
| 1 |
BlackRock
New York
|
$107M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
$45.1M |
| 3 |
State Street
Boston,
Massachusetts
|
$55.1M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$22M |
| 5 |
Morgan Stanley
New York
|
$25.8M |
Top Sellers
| 1 |
RI
RTW Investments
New York
|
$15.7M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
$2.34M |
| 3 |
BC
Boxer Capital
San Diego,
California
|
$103M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$16.8M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
$26.5M |
